Physician profile
Lucy Li
NPI 1861955502
$1,803.62
in general payments reported to CMS, 2019-2025
13 companies · $459 in 2025
The $459 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $59.06 · 2024: $1,285 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,080 · Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,079.99 |
| Food and Beverage | $723.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,000.00 | 2024 | |
| Astellas Pharma US INC | $272.47 | 2024-2025 | Veozah |
| Organon LLC | $137.00 | 2025 | |
| Sumitomo Pharma America, INC. | $102.06 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $64.50 | 2024-2025 | Slynd |
| Pfizer INC. | $58.42 | 2023-2024 | |
| Axonics, INC. | $33.79 | 2024 | Axonics |
| Sage Therapeutics, LLC | $31.30 | 2024 | |
| Mayne Pharma Commercial LLC | $25.94 | 2025 | |
| Dexcom, INC. | $24.55 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $21.30 | 2025 | Evenity, Prolia |
| Cumberland Pharmaceuticals, INC. | $16.59 | 2024 | Caldolor |
| Millicent US INC | $15.70 | 2025 | Intrarosa, Femring |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.